100 Results (Page 1 of 9)
Egypt Markets Research Reports
Egypt Diabetes Devices Market Analysis
The Egypt Diabetes Devices Market is expected to witness growth from $64 Mn in 2022 to $124 Mn in 2030 with a CAGR of 8.70% for the forecasted year 2022-2030. As healthcare expenditures in Egypt increase, a greater focus is being placed on preventive care and the management of chronic diseases. The demand for healthcare goods in general, including diabetes management devices, ought to increase as a result. The market is segmented by type and by the end user. Some key players in this market include JK Medirise, EGMED, Johnson & Johnson, Medtronic, Roche, Ascensia Diabetes Care and Dexcom.
Egypt Cardiac Surgery Instruments Market Analysis
The Egypt Cardiac Surgery Instruments Market is expected to witness growth from $6 Mn in 2022 to $11 Mn in 2030 with a CAGR of 8.10% for the forecasted year 2022-2030. In Egypt, cardiac conditions like coronary artery disease and heart failure are extremely prevalent. The need for the instruments used in these procedures is growing as a consequence of the rise in cardiac surgeries. The market is segmented by type, application and by end user. Some key players in this market include JK Medirise, EGMED, LivaNova, B. Braun, Medline Industries, KLS Martin, and STILLE.
Egypt Anti Aging Therapeutics Market Analysis
Egypt anti-aging therapeutics market is expected to witness growth from $2 Mn in 2022 to $6 Mn in 2030 with a CAGR of 18.03% for the year 2022-2030. Egypt’s rising elderly population and their subsequent demand for innovative anti-aging treatments are responsible for the growth of the market during the forecast period. The Egypt anti-aging therapeutics market is segmented by product, treatment, target group, type of aging, type of molecules, mechanism of action, ingredient, and by distribution channel. Some of the leading players in the market are CEB, Botogenix, and Intervene Immune.
Egypt Artificial Intelligence (AI) in Healthcare Market Analysis
Egypt's Artificial Intelligence (AI) in the healthcare market is projected to grow from $0.02 Bn in 2022 to $0.41 Bn by 2030, registering a CAGR of 46.72% during the forecast period of 2022-30. The market will be driven by population growth, the increasing prevalence of chronic diseases, and the availability of healthcare data. The market is segmented by healthcare components & by healthcare applications. Some of the major players include IBM Watson Health, Philips Healthcare & Fawry Healthcare.
Egypt Biomaterials in Healthcare Market Analysis
The Egypt Biomaterials in Healthcare Market is expected to witness growth from $438 Mn in 2022 to $1311 Mn in 2030 with a CAGR of 14.70% for the forecasted year 2022-2030. As Egypt's population ages, there is a growing demand for biomaterials to treat conditions like osteoarthritis, spine issues, and cardiovascular disease. The market is segmented by type and by application. Some key players in this market include: MedNotch, Procare, BASF SE, Johnson and Johnson, Medtronic and Evonik Industries.
Egypt Healthcare Financial Analytics Market Analysis
The Egypt Healthcare Financial Analytics market size was valued at $xx Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 8.3% from 2022 to 2030 and will reach $xx Mn in 2030. The market is segmented by type, component, and deployment. Egypt’s Healthcare Financial Analytics market will grow as the rising prevalence of chronic diseases in Egypt, such as diabetes, cancer, and cardiovascular disease. The key market players are Clinsoft, Infrahealth, Naseej, Medisoft, Redcliffe Life Sciences, and others.
Egypt Healthcare Claims Management Market Analysis
The Egypt healthcare claims management market is projected to grow from $74.76 Mn in 2022 to $442.76 Mn by 2030, registering a CAGR of 24.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be rising health insurance coverage, increasing patient awareness and expectations, government initiatives and growing demand for digital healthcare technology. The market is segmented by component, type, delivery mode and by end-user. Some of the major players include MedMisr, Marsh, Cigna, Allianz and Accenture.
Egypt Healthcare Insurance Market Analysis
The Egypt healthcare insurance market is projected to grow from $5.67 Bn in 2022 to $11.39 Bn by 2030, registering a CAGR of 9.1% during the forecast period of 2022 - 2030. The main factors driving the growth would be increasing population, government initiatives, technological advancements and rising awareness. The market is segmented by the component, provider, coverage, by health insurance plans and end-user. Some of the major players include Misr Insurance, Suez Canal Life Insurance, Mohandes Insurance, Allianz and BUPA.
Egypt ADHD (Attention Deficit Hyperactivity Disorder) Therapeutic Market Analysis
Egypt's Attention Deficit Hyperactivity Disorder (ADHD) therapeutics market is expected to witness growth from $83 Mn in 2022 to $165 Mn in 2030 with a CAGR of 9% for the year 2022-30. The market is projected to expand during the forecast period as the incidence of ADHD increases in Egypt. The Egypt ADHD therapeutics market is segmented by drug, drug type, demographics, and by distribution channel. Clavita Pharma, Zeta Pharma, and Takeda are the major competitors in the market.
Egypt Liver Diseases Therapeutics Market Analysis
By 2030, it is anticipated that the Egypt Liver Disease Therapeutics market will reach a value of $113 Mn from $65 Mn in 2022, growing at a CAGR of 7.2% during 2022-2030. Liver Disease Therapeutics in Egypt is dominated by domestic pharmaceutical companies such as Pharco Pharmaceuticals, Delta Pharma, and EIPICO. The Liver Disease Therapeutics market in Egypt is segmented into different types of disease and different therapy types. Some of the significant factors affecting the Egypt Liver Disease Therapeutics market are the growing prevalence of liver diseases and unhealthy and dynamic lifestyles.
Egypt Home Healthcare Market Analysis
The Egypt home healthcare market size was valued at $1.015 Bn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 9.43% from 2022 to 2030 and will reach $2.08 Bn in 2030. The home healthcare market in Egypt has seen significant growth in recent years due to a variety of factors, including an aging population, increasing rates of chronic diseases, and a growing awareness of the benefits of receiving medical care at home. The market is segmented by device type, service type, and indication type. The key players in Egypt’s home healthcare market are GE Healthcare, Abbott., Philips, Siemens Healthineers, and others.
Egypt Oncology Clinical Trials Market Analysis
Egypt's oncology clinical trials market is projected to grow from $35.4 Mn in 2022 to $60.9 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022-30. The market will be driven by Egypt's rising cancer incidence and the government's favorable regulatory framework for clinical trials. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer Inc., Novartis International, EIPICO & EVA Pharma
Egypt Oral Care Market Analysis
The Egypt Oral Care market was valued at $99 Mn in 2022 and is estimated to expand at a CAGR of 7.7% from 2022 to 2030 and will reach $179 Mn in 2030. One of the main reasons propelling the growth of this market is introduction of newer technologies, a increasing urbanization. The market is segmented by type, drug and distribution channel. Some key players in this market are Marico Egypt, Amoun Pharmaceutical Company, Eva Pharma, Siwa Holding, Pharco Pharmaceuticals, among others.
Egypt Multiple Myeloma Therapeutics Market Analysis
The Egypt Multiple Myeloma Therapeutics Market was valued at $23 Bn in 2022 and is estimated to expand at a CAGR of 6% from 2022 to 2030 and will reach $37 Bn in 2030. One of the main reasons propelling the growth of this Market is Growing awareness and diagnosis, Technological advancements. The Market is segmented by type, drug and distribution channel. Some key players in this Market are EIPICO, Amoun Pharmaceutical Company, Pharco Pharmaceuticals, Delta Pharma, MEMI Pharmaceuticals and others.
Egypt Neurology Devices Market Analysis
The Egypt Neurology Device Market is expected to witness growth from $35 Mn in 2022 to $72 Mn in 2030 with a CAGR of 9.30% for the forecasted year 2022-2030. There is a rising need for neurology devices in Egypt due to the frequency of neurological disorders such as stroke, epilepsy, Parkinson's disease, and multiple sclerosis. The market is segmented by product type and by the end user. Major Key players in Malaysia's neurology devices market include Wassenburg Medical, EMG-EP Technologies, Johnson and Johnson, GE Healthcare, Stryker, Medtronic and Abbott laboratories.
Egypt Connected Healthcare Market Analysis
The Egypt-connected healthcare market is projected to grow from $185.81 Mn in 2022 to $1506.39 Mn by 2030, registering a CAGR of 29.9% during the forecast period of 2022 - 2030. The main factors driving the growth would be increased adoption of digital technology, rising demand for healthcare services, improving internet penetration and government support. The market is segmented by type, function and by application. Some of the major players include 7keema, Tabibi 24/7, 3elagi, Siemens Healthineers, Microsoft and Apple.
Egypt Primary Hyperoxaluria (PH) Therapeutics Market Analysis
The Egypt Primary Hyperoxaluria (PH) Therapeutics Market was valued at $XX Bn in 2022 and is estimated to expand at a CAGR of 6.3% from 2022 to 2030 and will reach $XX Bn in 2030. One of the main reasons propelling the growth of this government initiatives, increasing prevalence. The market is segmented by diagnostic method, by treatment, and by type. Some key players in this market are Alnylam Pharmaceuticals, Dicerna Pharmaceuticals, OxThera AB, Saudi German Hospitals Group, and Dar Al Fouad Hospital, among others.
Egypt Neurology Clinical Trials Market Analysis
The Egypt Neurology Clinical Trials market is projected to grow from $14.6 Mn in 2022 to $25.2 Mn by 2030, registering a CAGR of 7% during the forecast period of 2022 - 2030. The market will be driven by the increasing involvement from both global and local companies, a supportive regulatory environment and a growing pool of qualified professionals. The market is segmented by phase, by study design & by indication. Some of the major players include Pfizer, Novartis, Minapharm Pharmaceuticals & EIPICO.
Egypt 3D Printing Medical Devices Market Analysis
The Egypt 3D Printing Medical Devices market size was valued at $8 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 17.8% from 2022 to 2030 and will reach $31 Mn in 2030. The market is segmented by component, application, technology, and end user. The Egypt 3D Printing Medical Devices market will grow as the 3D printing technology has made a significant impact in the medical industry by enabling the production of personalized and complex medical devices. T The key market players are Some of the key players in the market include MOBILIS Medical, NovaBone Products, E2E Medical, Human Technology Lab, SymmetrySurgical, Stratasys, Materialise, Stryker, and others.
Egypt Chronic Obstructive Pulmonary Disease (COPD) Therapeutics Market Analysis
The Egypt COPD Therapeutics Market was valued at $51 Mn in 2022 and is estimated to expand at a CAGR of 8.6% from 2022 to 2030 and will reach $99 Mn in 2030. One of the main reasons propelling the growth of this market is government initiatives, Aging population. The market is segmented by Drug class and By distribution channel. Some key players in this market are EIPICO, Pharco, Amoun, Memphis Pharmaceutical, Eva Pharma, Almirall, Astellas Pharma, American hospital of Paris, Boehringer Ingelheim Pharmaceuticals, Novartis, Pfizer, and others.
Egypt Teleradiology Market Analysis
The Egypt Teleradiology market size was valued at $7 Mn in 2022 and is estimated to expand at a compound annual growth rate (CAGR) of 13.2% from 2022 to 2030 and will reach $ 18 Mn in 2030. The market is segmented by application, modality, technology solutions, and end user. The Egypt teleradiology market will grow due to advancements in technology, such as electronic medical records (EMRs) and picture archiving and communication systems (PACS), have made it easier to transmit and store medical images securely. The key market players are Alborg Laboratories & Radiology Services, Alfa Labs, Cairo Scan Radiology & Labs, Egypt Radiology Group, Ebtisama Radiology, MedMark Teleradiology, Mena Medical Solutions, Radiology Group, Telemedica Egypt and others.
Egypt Infectious Disease Therapeutics Market Analysis
By 2030, it is anticipated that the Egypt infectious disease therapeutics market will reach a value of $528.93 Mn from $335.64 Mn in 2022, growing at a CAGR of 5.9% during 2022-2030. The Infectious Disease Therapeutics in Egypt is dominated by a few domestic pharmaceutical companies such as EIPICO, Pharco Pharmaceuticals and Memphis Pharmaceutical. The Infectious Disease Therapeutics market in Egypt is segmented into different therapeutic areas and different diseases type. The major factors affecting the Egypt infectious disease therapeutics market are the increasing disease burden of communicable diseases like TB, hepatitis, and COVID-19 and the amount of healthcare funding for infectious diseases treatment in various of areas of Egypt.
Egypt Clinical Diagnostics Market Analysis
Egypt's clinical diagnostic market was valued at $193 Mn in 2022 and is estimated to expand at a CAGR of 7.5% from 2022-30 and will reach $344 Mn in 2030. One of the main reasons propelling the growth of this market is an increase in chronic disease and the aging population. The market is segmented by type, drug, and distribution channel. Some key players in this market are Biomedica Egypt, Al Borg Laboratories, NileDiagnostic, Delta Medical, Abbott, BioMérieux, Danaher Corporation, Roche, Siemens Healthineers, Beckman Coulter, and others.
Egypt Acne Therapeutics Market Analysis
Egypt's acne therapeutics market is projected to grow from $28 Mn in 2022 to $53 Mn in 2030 with a CAGR of 8.2% for the year 2022-2030. Major market drivers include the growing prevalence of acne and the demand for novel therapeutics such as hormonal therapy for its treatment in Egypt. The Egypt acne therapeutics market is segmented by treatment, route of administration, age group, and by distribution channel. Copad Pharma, Delta Pharma, and Proactiv Company Sàrl are the key players in the market.
Egypt Patient Engagement Solutions Market Analysis
The Egypt patient engagement solutions market is projected to grow from $47.63 Mn in 2022 to $133.03 Mn by 2030, registering a CAGR of 13.7% during the forecast period of 2022 - 2030. The main factors driving the growth would be as growing awareness, digital transformation of healthcare and government support. The market is segmented by component, delivery mode, application, therapeutic area, functionality and by end-user. Some of the major players include AlMokhtabar, Curawella, Siemens Healthineers, Dedalus and Oracle.